drugset / Trial / NCT04432610

Echocardiographic Study of a Single Dose Bisoprolol Versus Nebivolol in Healthy Subjects

NCT04432610

Phase 4 Withdrawn Clinical Hospital Center Zemun
RandomizedCrossoverDouble-blindOther

Summary

This is a randomized, double-blind, crossover study in healthy adult subjects. Each subject will receive a single dose of bisoprolol 5 mg p.o. and nebivolol 5 mg p.o. with 1 week washout period. All subjects will undergo a physical examination, 12-lead electrocardiography and a comprehensive echocardiographic study before the administration of the study drug and 5 hours thereafter.

Timeline

Start
2030-01
Primary completion
2030-12
Completion
2030-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisoprolol Other / unclassified 5 mg Oral
Subject Nebivolol Other / unclassified 5 mg Oral

Indications

No indication recorded.